Post by
gojotv! on Mar 15, 2023 2:11pm
I don't understand why...
...the company won't inform shareholders about the BTD (and possible AA) application with the FDA. IR refuses to say if it's even been filed.
They claim it's not "material", but as far as I can see, the share price right now entirely hinges on this news... Are shareholders not entitled to know if stated timelines are being respected? Or if there's a hold up - why?
I just don't like when companies give their shareholders the radio silence. It's never good.
Crossing my fingers I'm wrong...
GLTA real investors!
Comment by
Longholder99 on Mar 15, 2023 2:36pm
If they applied it isn't meaningful frankly as until it's approved the company is no further ahead. If they announced said application the market would likely respond as it has. Based on ability to generate revenue which will not change until the game changing cancer treatment we have all invested in can be sold to consumers. Like any other business.
Comment by
Eoganacht on Mar 15, 2023 3:06pm
We've had "radio silence" numerous time over the years with Theralase. Occasionally there's bad news, but 9 times out of 10 it's all good. Big picture? Theralase has got this.